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Introduction
The body sodium imbalance (dysnatremias) may be
associated with increased mortality of critically ill
patients. Evidence suggests that changes in the serum
sodium level on admission to the intensive care unit
(ICU), may lead to a poor outcome.
Objectives
The objective of this study was to evaluate the ability of
APACHE II and serum sodium levels to predict mortal-
ity of surgical critically ill patients.
Methods
One hundred and ninety-five surgical patients (62 %
males and 38% females; mean age of 51.8 ± 17.3 years)
admitted to the ICU in the post-operative phase were
retrospectively studied. The patients were divided into
survivors (n=152) and nonsurvivors (n=43). APACHE II,
and serum sodium levels at admission, 48-h and
discharge were recorded. The capability of each index
(APACHE II, Sodium-admission, sodium 48-h and
sodium-discharge) to predict mortality of surgical
patients was analysed by receiver-operator characteristic
curves (ROC). Odds ratios (OR) and 95% confidence
interval (CI) for hyponatremia (Na< 136 mmol/L) and
hypernatremia (Na>144 mmol/L) were calculated.
Results
Comparison of data between survivors and nonsurvivors
is summarized in Table 1. The mean APACHE II was
16.3 ± 8.3 (13.6 ± 6.1 for survivors and 25.5 ± 8.5 non-
survivors). The area under the ROC curve for APACHE
II was 0.841 (0.782-0.889) and 0.721 (0.653-0.783), 0.754
(0.687-0.812), 0.720 (0.651-0.782) for serum sodium
level at admission, 48-h and discharge, respectively. OR
for hyponatremia and hypernatremia were 5.33 (1.77-
16.08) and 0.25 (0.1-0.65). The comparisons of ROC
curves for these indexes are depicted in figure 1.
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Table 1
Patients n = 195 Survivors n = 152 Nonsurvivors n = 43
Sex (M/F) 121/74 95/57 26/17
Age (years) 51.8 ± 17.1 51.5 ± 17.3 52.9 ± 16.8
APACHE II score 16.3 ± 8.3 13.6 ± 6.1 25.5 ± 8.5
Death risk (%) 25.3 ± 24.1 18 ± 17.3 50.6 ± 27.7
Mechanical ventilation (days) 2.6 ± 4.8 1.6 ± 3.6 6.13 ± 6.0
ICU length of stay (days) 4.3 ± 5.6 3.24 ± 3.8 8.2 ± 8.7
Hospital length of stay (days) 24 ± 21 23 ± 22 24 ± 20
Overall mortality (%) 22
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Conclusions
Even though APACHE II was the most effective index
to predict mortality in the surgical critically ill patients,
the serum sodium levels on admission may also be used
as predictor of outcome.
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